glp-1 for binge eating disorder Agonist Disorder: Evidence and Safety Do GLP-1 Medications Help With

Integrated lifestyle support

Research models where BPC-157 showed activity: Esophageal, gastric, and duodenal ulcers NSAID-induced small intestinal damage Colonic inflammation and ulceration Post-surgical anastomosis healing GI fistula closure In anastomosis research, BPC-157 improved healing in esophagogastric, jejunoileal, and colocolonic surgical connections

Weight loss Available in NZ = Liraglutide high dose (Saxenda, daily injection) Self-funding needed ($500-600/month) Not available in NZ = Semaglutide (Ozempic, Wegovy) or Tirzepatide (Mounjaro), as of May 2023 Side effects, particularly upper gastrointestinal, are common with GLP-1 agonist initiation

Many Americans May Need More Potassium White Plains, New York, November 15, 2016 During a recent analysis of potassium supplements sold in the U.S

For athletes, bodybuilders, or aging individuals seeking improvements in recovery, fat loss, lean muscle retention, and sleep quality , it provides one of the most refined and well-tolerated peptide options available today

In combination, astaxanthin, lutein, and zeaxanthin have been associated with improvements in visual sharpness, reduced eye fatigue, and enhanced contrast recovery after glare exposure.14 When you add it up, Astaxanthin+ takes a broader approach than most astaxanthin supplements by pairing a well-studied astaxanthin dose with two other extensively researched antioxidants